• Back to Cyclophilin 40 (Peptidyl-prolyl cis-trans isomerase D, PPIase D, 40 kDa peptidyl-prolyl cis-trans isomerase, CYP-40, Cyclophilin-related protein, Estrogen receptor-binding cyclophilin, Rotamase D, PPID, CYPD)

• Jandova J, Janda J and Sligh JE: Cyclophilin 40 alters UVA-induced apoptosis and mitochondrial ROS generation in keratinocytes. Exp Cell Res 2013; 319 (5):750-760
• Naoumov NV: Cyclophilin inhibition as potential therapy for liver diseases. Journal of Hepatology 2014; 61:1166-1174
• Park MS, Chu F, Xie J, Wang Y, Bhattacharya P, Chan WK: Identification of cyclophilin - 40-interacting proteins reveals potential cellular function of cyclohilin - 40. Analytical Biochemistry 2011; 410:257-265
• Pearson JD, Mohammed Z, Bacani JTC, Lai R and Ingham RJ: The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. BMC Cancer 2012; 12:229 1-14
• Ward BK, Mark PJ, Ingram DM, Minchin RF, Ratajczak T: Expression of the estrogen receptor associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Rest Treat 1999; 58:267-280
• Anderson LJ, Lin K, Compton T and Wiedmann B: Inhibition of cyclophilins alters lipid trafficking and blocks hepatis C virus secretion. Virology Journal 2011; 8:329 1-13
• Baker JD, Shelton LB, Yheng D, Favretto F, Nordhues BA, Darling A, Sullivan LE, Sun Z, Solanki PK, Martin MD, Suntharalingam A, Sabbagh JJ, Becker S, Mandelkow E, Uversky VN, Zweckstetter M, Dickey CHA, Koren III J, Blair LJ: Human cyclophilin 40 unravels neurotoxic amyloids. PLoS Biol 2017; 15(6): 1-22